Purpose of the KINETIC 2 TRIAL.
The purpose of this clinical research study is to evaluate the safety and efficacy of three different doses of an investigational drug compared to placebo on tremor reduction.
Who may be eligible to participate.
In order to be eligible, participants must meet the following criteria, in addition to other criteria:
- Be 18 to 80 years old
- Formally diagnosed with essential tremor for at least three years with localized upper limb tremors on both sides of the body
- Be willing to discontinue medications taken for the treatment of essential tremor, except propranolol, at least 14 days prior to the study and for the study’s duration
- Use an acceptable method of contraception
- Willing and able to comply with the study instructions
There are additional qualification requirements and substance use restrictions that the study doctor can explain to you. Eligible participants may receive reasonable compensation for their time and travel.